Charles Schwab Investment Management Inc Rhythm Pharmaceuticals, Inc. Transaction History
Charles Schwab Investment Management Inc
- $429 Billion
- Q1 2024
A detailed history of Charles Schwab Investment Management Inc transactions in Rhythm Pharmaceuticals, Inc. stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 406,745 shares of RYTM stock, worth $16.6 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
406,745
Previous 397,685
2.28%
Holding current value
$16.6 Million
Previous $18.3 Million
3.59%
% of portfolio
0.0%
Previous 0.0%
Shares
26 transactions
Others Institutions Holding RYTM
# of Institutions
176Shares Held
62.4MCall Options Held
880KPut Options Held
84.1K-
Primecap Management CO Pasadena, CA7.75MShares$316 Million0.25% of portfolio
-
Black Rock Inc. New York, NY6.53MShares$266 Million0.01% of portfolio
-
Baker Bros. Advisors LP New York, NY6.4MShares$261 Million3.51% of portfolio
-
Goldman Sachs Group Inc New York, NY5.11MShares$209 Million0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.3MShares$135 Million0.0% of portfolio
About RHYTHM PHARMACEUTICALS, INC.
- Ticker RYTM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 55,720,000
- Market Cap $2.27B
- Description
- Rhythm Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for the treatment of rare genetic diseases of obesity. The company's lead product candidate is IMCIVREE, a potent melanocortin-4 receptor for the treatment of pro-opiomelanocortin (POMC), proprotein convert...